MERIDIAN BIOSCIENCE INC (VIVO)
US5895841014 - Common Stock
| 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | 2019 (2019-9-30) | 2018 (2018-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 80.43M | 48.75M | 52.50M | 41.50M | 39.30M | |||
| Cash Equivalents | 1.03M | 1.02M | 1.00M | 20.90M | 20.40M | |||
| Receivables | 47.23M | 53.57M | 38.50M | 35.60M | 32.30M | |||
| Inventories | 67.81M | 76.84M | 61.30M | 39.60M | 42.00M | |||
| Other Current Assets | 14.10M | 12.63M | 8.90M | 7.10M | 5.00M | |||
| Total Current Assets | 210.60M | 192.81M | 162.20M | 144.80M | 139.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 50.71M | 49.00M | 37.50M | 30.60M | 30.00M | |||
| Goodwill | 116.30M | 114.67M | 114.20M | 89.20M | 54.60M | |||
| Intangibles | 74.13M | 84.15M | 83.20M | 60.20M | 23.10M | |||
| Other Non-Current Assets | 11.36M | 9.10M | 8.20M | 700.00K | 4.60M | |||
| Total Non-Current Assets | 252.50M | 256.92M | 243.10M | 180.70M | 112.30M | |||
| TOTAL ASSETS | 463.10M | 449.72M | 405.30M | 325.50M | 251.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 5.30M | |||
| Accrued Expenses | 25.72M | 30.97M | 23.80M | 11.70M | 12.30M | |||
| Accounts Payable | 17.76M | 11.70M | 12.00M | 7.20M | 6.30M | |||
| Other Current Liabilities | 14.47M | 4.49M | 16.70M | 2.00M | 300.00K | |||
| Total Current Liabilities | 57.95M | 47.16M | 52.50M | 20.90M | 24.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 25.00M | 60.00M | 68.80M | 75.80M | 44.90M | |||
| Deferred Taxes/Income | 578.00K | 1.05M | 3.80M | 2.50M | 3.80M | |||
| Other Non-Current Liabilities | 11.51M | 13.21M | 32.50M | 35.30M | 3.10M | |||
| Total Non-Current Liabilities | 37.09M | 74.26M | 105.10M | 113.60M | 51.80M | |||
| TOTAL LIABILITIES | 95.04M | 121.42M | 157.60M | 134.50M | 76.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 223.16M | 180.70M | 109.30M | 63.10M | 49.60M | |||
| Additional Paid In Capital | 155.66M | 147.40M | 140.20M | 132.80M | 129.20M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -259.00K | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -10.50M | 198.00K | -1.90M | -5.00M | -3.40M | |||
| Shares Outstanding | 43.76M | 43.36M | 43.10M | 42.70M | 42.40M | |||
| Tangible Book Value per Share | 4.06 | 2.99 | 1.16 | 0.97 | 2.30 | |||
| Total Shareholders' Equity | 368.06M | 328.30M | 247.60M | 191.00M | 175.40M | |||
| TOTAL LIABILITIES AND EQUITY | 463.10M | 449.72M | 405.30M | 325.50M | 251.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.07 | 0.18 | 0.28 | 0.40 | 0.26 | |||
| Current Ratio | 3.63 | 4.09 | 3.09 | 6.93 | 5.75 | |||
| Return On Assets (ROA) | 9.17% | 15.88% | 11.40% | 7.50% | 9.47% | |||
| Return On Equity (ROE) | 11.54% | 21.75% | 18.66% | 12.77% | 13.57% | |||
| Return On Invested Capital (ROIC) | 14.74% | 19.98% | 15.23% | 10.09% | 15.54% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 14.78% | 20.03% | 15.27% | 10.83% | 17.08% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 27.95% | 39.68% | 34.79% | 22.88% | 27.35% | |||
All data in USD